ACADIA Pharmaceuticals, Inc. (ACAD)
25.99
-0.54
(-2.04%)
USD |
NASDAQ |
Jan 16, 16:00
25.98
-0.01
(-0.04%)
After-Hours: 20:00
ACADIA Pharmaceuticals Market Cap: 4.397B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.421B |
| ANI Pharmaceuticals, Inc. | 1.905B |
| Catalyst Pharmaceuticals, Inc. | 2.790B |
| Regeneron Pharmaceuticals, Inc. | 77.04B |
| Puma Biotechnology, Inc. | 320.99M |
Market Cap Related Metrics
| PE Ratio | 16.72 |
| PS Ratio | 4.180 |
| PEG Ratio | 0.1653 |
| Price to Book Value | 4.794 |
| Price to Free Cash Flow | 44.23 |
| Price | 25.99 |
| Earnings Yield | 5.98% |
| PEGY Ratio | 0.1653 |
| Operating PE Ratio | 46.37 |
| Normalized PE Ratio | 16.72 |